MX2022012239A - Compuestos de amida y usos de los mismos. - Google Patents
Compuestos de amida y usos de los mismos.Info
- Publication number
- MX2022012239A MX2022012239A MX2022012239A MX2022012239A MX2022012239A MX 2022012239 A MX2022012239 A MX 2022012239A MX 2022012239 A MX2022012239 A MX 2022012239A MX 2022012239 A MX2022012239 A MX 2022012239A MX 2022012239 A MX2022012239 A MX 2022012239A
- Authority
- MX
- Mexico
- Prior art keywords
- amide compounds
- same
- symbol
- definition
- formula
- Prior art date
Links
- -1 Amide compounds Chemical class 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invención se relaciona con novedosos compuestos de amida de la Fórmula (I), composiciones farmacéuticas que comprenden los mismos, métodos para preparar los mismos y usos de los mismos, en donde la definición de cada símbolo es como se describe en la descripción. (ver Fórmula) (I).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010235798 | 2020-03-30 | ||
PCT/CN2021/083664 WO2021197276A1 (en) | 2020-03-30 | 2021-03-29 | Amide compounds and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2022012239A true MX2022012239A (es) | 2022-10-27 |
Family
ID=77927434
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2022012239A MX2022012239A (es) | 2020-03-30 | 2021-03-29 | Compuestos de amida y usos de los mismos. |
Country Status (15)
Country | Link |
---|---|
US (1) | US20230174513A1 (es) |
EP (1) | EP4126844A4 (es) |
JP (1) | JP2023520211A (es) |
KR (1) | KR20230012473A (es) |
CN (4) | CN117720520A (es) |
AR (1) | AR121674A1 (es) |
AU (1) | AU2021247733A1 (es) |
BR (1) | BR112022019517A2 (es) |
CA (1) | CA3178450A1 (es) |
CL (1) | CL2022002574A1 (es) |
IL (1) | IL296790A (es) |
MX (1) | MX2022012239A (es) |
PE (1) | PE20230823A1 (es) |
TW (1) | TW202144333A (es) |
WO (1) | WO2021197276A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW202413367A (zh) * | 2022-08-19 | 2024-04-01 | 財團法人國家衛生研究院 | Tam受體抑制劑 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110104161A1 (en) * | 2008-05-14 | 2011-05-05 | Burgess Teresa L | Combinations vegf(r) inhibitors and hepatocyte growth factor (c-met) inhibitors for the treatment of cancer |
US9012635B2 (en) * | 2013-03-15 | 2015-04-21 | Deciphera Pharmaceuticals, Llc | Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities |
EP3067356B1 (en) * | 2013-11-08 | 2018-07-04 | ONO Pharmaceutical Co., Ltd. | Pyrrolo pyrimidine derivative |
EP3239147B9 (en) * | 2014-12-25 | 2020-01-08 | Ono Pharmaceutical Co., Ltd. | Quinoline derivative |
JP2021536436A (ja) * | 2018-08-24 | 2021-12-27 | 南京薬捷安康生物科技有限公司Nanjing Transthera Biosciences Co., Ltd. | キノリン誘導体から調製される新規な阻害剤 |
CN110330479A (zh) * | 2019-07-19 | 2019-10-15 | 南京华威医药科技集团有限公司 | 一种用作axl抑制剂的抗肿瘤化合物及其用途 |
-
2021
- 2021-03-29 IL IL296790A patent/IL296790A/en unknown
- 2021-03-29 BR BR112022019517A patent/BR112022019517A2/pt unknown
- 2021-03-29 CA CA3178450A patent/CA3178450A1/en active Pending
- 2021-03-29 AR ARP210100765A patent/AR121674A1/es unknown
- 2021-03-29 KR KR1020227037728A patent/KR20230012473A/ko unknown
- 2021-03-29 CN CN202311688396.9A patent/CN117720520A/zh active Pending
- 2021-03-29 JP JP2022559760A patent/JP2023520211A/ja active Pending
- 2021-03-29 PE PE2022002136A patent/PE20230823A1/es unknown
- 2021-03-29 TW TW110111271A patent/TW202144333A/zh unknown
- 2021-03-29 MX MX2022012239A patent/MX2022012239A/es unknown
- 2021-03-29 CN CN202180023506.2A patent/CN115315422B/zh active Active
- 2021-03-29 US US17/995,172 patent/US20230174513A1/en active Pending
- 2021-03-29 WO PCT/CN2021/083664 patent/WO2021197276A1/en unknown
- 2021-03-29 EP EP21779668.9A patent/EP4126844A4/en active Pending
- 2021-03-29 CN CN202311688423.2A patent/CN117777103A/zh active Pending
- 2021-03-29 AU AU2021247733A patent/AU2021247733A1/en active Pending
- 2021-03-29 CN CN202311688364.9A patent/CN117720519A/zh active Pending
-
2022
- 2022-09-22 CL CL2022002574A patent/CL2022002574A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
IL296790A (en) | 2022-11-01 |
BR112022019517A2 (pt) | 2022-12-06 |
WO2021197276A1 (en) | 2021-10-07 |
JP2023520211A (ja) | 2023-05-16 |
CL2022002574A1 (es) | 2023-05-26 |
PE20230823A1 (es) | 2023-05-19 |
EP4126844A4 (en) | 2024-04-10 |
EP4126844A1 (en) | 2023-02-08 |
TW202144333A (zh) | 2021-12-01 |
KR20230012473A (ko) | 2023-01-26 |
US20230174513A1 (en) | 2023-06-08 |
AU2021247733A1 (en) | 2022-11-17 |
CN115315422B (zh) | 2023-11-07 |
CN115315422A (zh) | 2022-11-08 |
CN117720519A (zh) | 2024-03-19 |
CA3178450A1 (en) | 2021-10-07 |
CN117720520A (zh) | 2024-03-19 |
AR121674A1 (es) | 2022-06-29 |
CN117777103A (zh) | 2024-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2023012054A (es) | Inhibidor derivado heterociclico y metodo de preparacion y su aplicacion. | |
MX2020009234A (es) | Compuestos de heteroarilo como inhibidores de cinasas asociadas con receptores de interleucina-1 (irak) tipo ii y usos de los mismos. | |
TN2018000410A1 (en) | New piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them | |
TW200621777A (en) | New dihydropteridione derivatives, process for their manufacture and their use as medicament | |
TW200621262A (en) | New dihydropteridione derivatives, process for their manufacture and their use as medicament | |
TN2017000521A1 (en) | New aminoacid derivatives, a process for their preparation and pharmaceutical compositions containing them | |
TW200611904A (en) | Aza-bicyclononanes | |
TW200745004A (en) | Novel compounds, their preparation and use | |
JO2734B1 (en) | Organic compounds | |
MX2021000093A (es) | Antagonistas del receptor de tipo toll 7/8 (tlr7/8) y usos de los mismos. | |
RS51661B (en) | NEW DIOSMETHINE DERIVATIVES, THE PROCEDURE FOR THEIR MAKING AND THE PHARMACEUTICAL MIXTURES CONTAINING THEM | |
DE602004024213D1 (en) | Aminopropanolderivate | |
MX2022010219A (es) | Compuestos heterociclicos de heteroarilo y usos de los mismos. | |
MX2021011823A (es) | Derivado pirroloheterociclico, metodo de preparacion del mismo y su aplicacion en medicina. | |
MX2020006370A (es) | Pirazolopiridina-diamidas, su uso como insecticida y procesos para prepararlas. | |
ZA202201364B (en) | Deuterated compounds for use in the treatment of cancer | |
MX2023007265A (es) | Inhibidores de cdk y su uso como productos farmacéuticos. | |
MX2020007562A (es) | Nuevas antranilamidas, su uso como insecticida y procesos para su preparacion. | |
MX2023009190A (es) | Compuestos triciclicos y usos de los mismos. | |
TN2021000025A1 (en) | Novel heterocyclic amine derivative and pharmaceutical composition comprising same | |
MX2021014680A (es) | Derivado de benzotriazol. | |
CR20220004A (es) | Nuevos compuestos heterocíclicos | |
MX2023003443A (es) | Inhibidores de la proteína cinasa alfa 1 y métodos de uso. | |
PH12021550788A1 (en) | New amino-pyrimidonyl-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them | |
MX2023003183A (es) | Compuestos heterociclicos de heteroarilo y usos de los mismos. |